STOCK TITAN

Bullfrog AI Holdings Inc - BFRGW STOCK NEWS

Welcome to our dedicated news page for Bullfrog AI Holdings (Ticker: BFRGW), a resource for investors and traders seeking the latest updates and insights on Bullfrog AI Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bullfrog AI Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bullfrog AI Holdings's position in the market.

Rhea-AI Summary
BullFrog AI Holdings, Inc. announces Chief Scientific Officer's presentation on Quantum Assisted AI/ML for Precision Medicine at Bio-IT World Conference & Expo. The presentation focuses on using quantum methods to analyze disease patterns, including multi-omics cancer data and severe COVID-19 patient classification, showcasing the potential of quantum computing in revolutionizing precision medicine.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
conferences AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the availability of a fireside chat recording featuring CEO Vin Singh and Dr. Daniel Weinberger. The collaboration with Lieber Institute for Brain Development explores psychiatric conditions using advanced graph analytics on 2,800 brain samples, revealing potential biological subtypes within disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.49%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. appoints Dr. Thomas W. Chittenden as Chief Scientific Officer, bringing extensive experience in AI, machine learning, and drug discovery. Dr. Chittenden's leadership is expected to drive innovation in drug development and accelerate BullFrog AI's mission.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.69%
Tags
management AI
Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the Underwriter's decision to exercise their over-allotment option to purchase 218,382 shares of the Company's common stock. The offering was made via a prospectus filed with the SEC and facilitated by WallachBeth Capital, LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. announces a fireside chat with CEO Vin Singh and Dr. Daniel R. Weinberger to discuss groundbreaking collaboration with LIBD on psychiatric research using AI and machine learning. The partnership aims to provide new insights into brain disorders and potential treatments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.15%
Tags
AI
-
Rhea-AI Summary
WallachBeth Capital LLC announced that BullFrog AI Holdings, Inc. has completed an underwritten public offering, raising approximately $5.7 million. The company offered 1,507,139 shares of common stock at a public offering price of $3.782 per share. Additionally, the underwriters have a 45-day option to purchase an additional 226,071 shares to cover over-allotments. The offering was managed by WallachBeth Capital, LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
Rhea-AI Summary
BullFrog AI Holdings, Inc. (NASDAQ:BFRG) has closed an underwritten public offering, raising approximately $5,700,000 in gross proceeds. The company intends to use the net proceeds for working capital and general corporate purposes. WallachBeth Capital, LLC acted as the sole book-running manager for the offering. The offering was made in accordance with a registration statement on Form S-1 (File No. 333-276740) filed with the SEC and became effective on January 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
-
Rhea-AI Summary
WallachBeth Capital LLC announced that BullFrog AI Holdings, Inc. priced an underwritten public offering of 1,507,139 shares of common stock and accompanying warrants, with gross proceeds of approximately $5,700,000. The offering is expected to close on February 5, 2024, subject to customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.34%
Tags
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. announced the pricing of an underwritten public offering of an aggregate of 1,507,139 shares of common stock and accompanying warrants to purchase 1,507,139 shares of common stock at a public offering price of $3.782 per share, resulting in gross proceeds of approximately $5,700,000. The company also granted the underwriters a 45-day option to purchase an additional 226,071 shares of common stock and/or warrants to cover over-allotments. The net proceeds from the offering will be used for working capital and other general corporate purposes. The offering is expected to close on February 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.34%
Tags
Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the appointment of two distinguished scientific advisors to its advisory board, Dr. Gwenn S. Smith and Dr. Jeremiah Wala. Dr. Smith brings expertise in brain imaging and neuropsychiatry, while Dr. Wala adds clinical insight and computational expertise to the company's scientific advisory board. Both advisors are expected to contribute to the company's mission of developing breakthrough therapies and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.18%
Tags
management AI
Bullfrog AI Holdings Inc

Nasdaq:BFRGW

BFRGW Rankings

BFRGW Stock Data

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services